Literature DB >> 2280578

[Serum level and organ deposits of beta 2-microglobulin in dialysis patients].

G Stein1, A Schneider, H Toss, R Linke, K Schaefer, E Ritz.   

Abstract

In radioimmunological estimation of beta 2-microglobulin (beta 2m) significant higher serum values were found in 36 dialysis patients (44.4 +/- 20.3 mg/l) in comparison with healthy probands (1.5 +/- 0.2 mg/l). A significant relation to the duration of dialysis, diuresis, symptoms of the musculo-skeletal system, but not to radiologic changes or bone biopsy findings could be seen. Post mortem examinations carried out in 21 dialysis patients revealed AB-amyloid deposits in synovial tissue of different joints (particularly shoulder and hip joint) or intervertebral discs in eight patients (age 48 to 73 years, dialysis duration less than four years) without correlation to serum beta 2m level or radiographically suspect areas. In the tissue of cervical spine or intervertebral discs of two patients suffering from destructive spondylarthropathy no amyloid could be detected. These results suggest that AB-amyloid may occur in elderly patients early in the course of hemodialysis and may be asymptomatic in most cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280578     DOI: 10.1007/bf01798067

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

Review 1.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Amyloid deposits in patients on long-term hemodialysis are not always beta-2-microglobulin related.

Authors:  T Morita; A Kamimura; Y Hirasawa
Journal:  Nephron       Date:  1988       Impact factor: 2.847

3.  Systemic character and visceral involvement of dialysis amyloidosis.

Authors:  J M Campistol; A Torras; J Lopez-Pedret
Journal:  Clin Nephrol       Date:  1987-11       Impact factor: 0.975

4.  [Hemodialysis: carpal tunnel syndrome and amyloid substance].

Authors:  H Assenat; E Calemard; B Charra; G Laurent; J C Terrat; T Vanel
Journal:  Nouv Presse Med       Date:  1980-05-31

5.  Erosive azotemic osteoarthropathy: possible role of amyloidosis.

Authors:  J P Huaux; H Noël; J Malghem; B Maldague; J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Arthritis Rheum       Date:  1985-09

6.  [Clinical significance of beta 2 microglobulin determination in dialysis patients].

Authors:  G Stein; H Carlsohn; K Schaefer; K Abendroth; I Marzoll; H Sperschneider; K Günther; G Wessel
Journal:  Z Urol Nephrol       Date:  1989-05

7.  [Destructive spondylarthropathy with amyloid deposits in 3 patients on chronic hemodialysis].

Authors:  J L Sébert; P Fardellone; H Deramond; A Marie; J Lansaman; T Bardin; G Lambrey; J D Gheerbrant; D Legars; P Galibert
Journal:  Rev Rhum Mal Osteoartic       Date:  1986 Jul-Sep

8.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

9.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Serum beta2-microglobulin in hemodialyzed patients.

Authors:  C Vincent; J P Revillard; M Galland; J Traeger
Journal:  Nephron       Date:  1978       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.